Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains
- PMID: 8480510
- DOI: 10.1007/BF00334445
Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains
Abstract
The colocalization of beta amyloid protein with the enzymes acetyl- and butyrylcholinesterase was assessed using immunocytochemistry for beta amyloid protein and a sensitive histochemical technique for cholinesterases. In non-demented aged and Alzheimer's disease brains, double-stained sections for cholinesterases and thioflavin-S showed that all thioflavin-S-positive plaques were also positive for cholinesterases, indicating the presence of these enzymes in all plaques with beta-pleated amyloid protein. When amyloid angiopathy was present, cholinesterases were also observed in amyloid-laden vessels walls. Comparison of series of adjacent sections alternatively stained for acetylcholinesterase, beta amyloid protein and butyrylcholinesterase, as well as by double histo-immunocytochemical staining, showed either cholinesterase in a proportion of the preamyloid diffuse plaques. These data indicate that cholinesterases are associated with the amyloid protein from very early stages, when the beta-pleated structure is being formed. Novel functions attributed to acetyl- and butyrylcholinesterase, such us their proteolytic activity either by themselves or in association with heparan sulfate proteoglycans, may play a role in the aggregation or the consolidation processes taking place at the early stages of diffuse plaque formation.
Similar articles
-
Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains.Acta Neuropathol. 1994;87(3):284-92. doi: 10.1007/BF00296744. Acta Neuropathol. 1994. PMID: 8009960
-
Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.J Nucl Med. 2016 Feb;57(2):297-302. doi: 10.2967/jnumed.115.162032. Epub 2015 Nov 5. J Nucl Med. 2016. PMID: 26541777
-
Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients.Mol Chem Neuropathol. 1997 Apr;30(3):161-73. doi: 10.1007/BF02815095. Mol Chem Neuropathol. 1997. PMID: 9165483
-
Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.Am J Pathol. 1993 May;142(5):1449-57. Am J Pathol. 1993. PMID: 7684195 Free PMC article. Review.
-
A review on cholinesterase inhibitors for Alzheimer's disease.Arch Pharm Res. 2013 Apr;36(4):375-99. doi: 10.1007/s12272-013-0036-3. Epub 2013 Feb 24. Arch Pharm Res. 2013. PMID: 23435942 Review.
Cited by
-
Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.Neurochem Res. 2005 Jun-Jul;30(6-7):895-908. doi: 10.1007/s11064-005-6962-9. Neurochem Res. 2005. PMID: 16187224 Review.
-
Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer's Disease and Future Perspectives.J Alzheimers Dis Rep. 2022 Apr 18;6(1):177-193. doi: 10.3233/ADR-210061. eCollection 2022. J Alzheimers Dis Rep. 2022. PMID: 35591949 Free PMC article. Review.
-
Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and amyloid precursor protein (AβPP) expression in rat brain.Indian J Pharmacol. 2012 Sep-Oct;44(5):593-8. doi: 10.4103/0253-7613.100383. Indian J Pharmacol. 2012. PMID: 23112420 Free PMC article.
-
Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease.Mol Neurodegener. 2010 Jan 18;5:4. doi: 10.1186/1750-1326-5-4. Mol Neurodegener. 2010. PMID: 20205793 Free PMC article.
-
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.Drugs Aging. 2004;21(7):453-78. doi: 10.2165/00002512-200421070-00004. Drugs Aging. 2004. PMID: 15132713 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical